Report Detail

Pharma & Healthcare Global Icatibant Acetate Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4733268
  • |
  • 24 August, 2026
  • |
  • Global
  • |
  • 105 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Icatibant Acetate Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Icatibant acetate injection is a synthetic bradykinin B2 receptor antagonist used to treat acute attacks of hereditary angioedema (HAE). Administered subcutaneously, icatibant provides rapid relief from symptoms like facial, throat, or abdominal swelling, and is a key treatment option for managing acute HAE attacks.
This report is a detailed and comprehensive analysis for global Icatibant Acetate Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Icatibant Acetate Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Icatibant Acetate Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Icatibant Acetate Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Icatibant Acetate Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Icatibant Acetate Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Icatibant Acetate Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals, Eugia Pharma Specialities, Glenmark Pharmaceuticals, Sandoz, Cipla, Fresenius Kabi, Jiangsu Hengrui Pharmaceuticals, Chengdu Shengnuo Biology Pharmacy, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Icatibant Acetate Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Original Drug
Generic Drug
Market segment by Application
Hospital and Clinic
Pharmacy
Other
Major players covered
Takeda Pharmaceuticals
Eugia Pharma Specialities
Glenmark Pharmaceuticals
Sandoz
Cipla
Fresenius Kabi
Jiangsu Hengrui Pharmaceuticals
Chengdu Shengnuo Biology Pharmacy
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Icatibant Acetate Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Icatibant Acetate Injection, with price, sales quantity, revenue, and global market share of Icatibant Acetate Injection from 2021 to 2026.
Chapter 3, the Icatibant Acetate Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Icatibant Acetate Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Icatibant Acetate Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Icatibant Acetate Injection.
Chapter 14 and 15, to describe Icatibant Acetate Injection sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Icatibant Acetate Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Original Drug
    • 1.3.3 Generic Drug
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Icatibant Acetate Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Pharmacy
    • 1.4.4 Other
  • 1.5 Global Icatibant Acetate Injection Market Size & Forecast
    • 1.5.1 Global Icatibant Acetate Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Icatibant Acetate Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Icatibant Acetate Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Takeda Pharmaceuticals
    • 2.1.1 Takeda Pharmaceuticals Details
    • 2.1.2 Takeda Pharmaceuticals Major Business
    • 2.1.3 Takeda Pharmaceuticals Icatibant Acetate Injection Product and Services
    • 2.1.4 Takeda Pharmaceuticals Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Takeda Pharmaceuticals Recent Developments/Updates
  • 2.2 Eugia Pharma Specialities
    • 2.2.1 Eugia Pharma Specialities Details
    • 2.2.2 Eugia Pharma Specialities Major Business
    • 2.2.3 Eugia Pharma Specialities Icatibant Acetate Injection Product and Services
    • 2.2.4 Eugia Pharma Specialities Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Eugia Pharma Specialities Recent Developments/Updates
  • 2.3 Glenmark Pharmaceuticals
    • 2.3.1 Glenmark Pharmaceuticals Details
    • 2.3.2 Glenmark Pharmaceuticals Major Business
    • 2.3.3 Glenmark Pharmaceuticals Icatibant Acetate Injection Product and Services
    • 2.3.4 Glenmark Pharmaceuticals Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.4 Sandoz
    • 2.4.1 Sandoz Details
    • 2.4.2 Sandoz Major Business
    • 2.4.3 Sandoz Icatibant Acetate Injection Product and Services
    • 2.4.4 Sandoz Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sandoz Recent Developments/Updates
  • 2.5 Cipla
    • 2.5.1 Cipla Details
    • 2.5.2 Cipla Major Business
    • 2.5.3 Cipla Icatibant Acetate Injection Product and Services
    • 2.5.4 Cipla Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cipla Recent Developments/Updates
  • 2.6 Fresenius Kabi
    • 2.6.1 Fresenius Kabi Details
    • 2.6.2 Fresenius Kabi Major Business
    • 2.6.3 Fresenius Kabi Icatibant Acetate Injection Product and Services
    • 2.6.4 Fresenius Kabi Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Fresenius Kabi Recent Developments/Updates
  • 2.7 Jiangsu Hengrui Pharmaceuticals
    • 2.7.1 Jiangsu Hengrui Pharmaceuticals Details
    • 2.7.2 Jiangsu Hengrui Pharmaceuticals Major Business
    • 2.7.3 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Product and Services
    • 2.7.4 Jiangsu Hengrui Pharmaceuticals Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
  • 2.8 Chengdu Shengnuo Biology Pharmacy
    • 2.8.1 Chengdu Shengnuo Biology Pharmacy Details
    • 2.8.2 Chengdu Shengnuo Biology Pharmacy Major Business
    • 2.8.3 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Product and Services
    • 2.8.4 Chengdu Shengnuo Biology Pharmacy Icatibant Acetate Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Chengdu Shengnuo Biology Pharmacy Recent Developments/Updates

3 Competitive Environment: Icatibant Acetate Injection by Manufacturer

  • 3.1 Global Icatibant Acetate Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Icatibant Acetate Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Icatibant Acetate Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Icatibant Acetate Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Icatibant Acetate Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Icatibant Acetate Injection Manufacturer Market Share in 2025
  • 3.5 Icatibant Acetate Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Icatibant Acetate Injection Market: Region Footprint
    • 3.5.2 Icatibant Acetate Injection Market: Company Product Type Footprint
    • 3.5.3 Icatibant Acetate Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Icatibant Acetate Injection Market Size by Region
    • 4.1.1 Global Icatibant Acetate Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Icatibant Acetate Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Icatibant Acetate Injection Average Price by Region (2021-2032)
  • 4.2 North America Icatibant Acetate Injection Consumption Value (2021-2032)
  • 4.3 Europe Icatibant Acetate Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Icatibant Acetate Injection Consumption Value (2021-2032)
  • 4.5 South America Icatibant Acetate Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Icatibant Acetate Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Icatibant Acetate Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Icatibant Acetate Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Icatibant Acetate Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Icatibant Acetate Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Icatibant Acetate Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Icatibant Acetate Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Icatibant Acetate Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Icatibant Acetate Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Icatibant Acetate Injection Market Size by Country
    • 7.3.1 North America Icatibant Acetate Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Icatibant Acetate Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Icatibant Acetate Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Icatibant Acetate Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Icatibant Acetate Injection Market Size by Country
    • 8.3.1 Europe Icatibant Acetate Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Icatibant Acetate Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Icatibant Acetate Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Icatibant Acetate Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Icatibant Acetate Injection Market Size by Region
    • 9.3.1 Asia-Pacific Icatibant Acetate Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Icatibant Acetate Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Icatibant Acetate Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Icatibant Acetate Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Icatibant Acetate Injection Market Size by Country
    • 10.3.1 South America Icatibant Acetate Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Icatibant Acetate Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Icatibant Acetate Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Icatibant Acetate Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Icatibant Acetate Injection Market Size by Country
    • 11.3.1 Middle East & Africa Icatibant Acetate Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Icatibant Acetate Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Icatibant Acetate Injection Market Drivers
  • 12.2 Icatibant Acetate Injection Market Restraints
  • 12.3 Icatibant Acetate Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Icatibant Acetate Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Icatibant Acetate Injection
  • 13.3 Icatibant Acetate Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Icatibant Acetate Injection Typical Distributors
  • 14.3 Icatibant Acetate Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Icatibant Acetate Injection. Industry analysis & Market Report on Icatibant Acetate Injection is a syndicated market report, published as Global Icatibant Acetate Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Icatibant Acetate Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report